Video & Podcasts

Video & Podcasts

thumbnail image

Pain Week 2023

September 2023

View our video from Pain Week 2023 in Las Vegas.


Drug Discovery World

Dr Lynn Kirkpatrick explains PF614-MPAR

Ensysce CEO, Dr. Lynn Kirkpatrick speaks with Megan Thomas of Drug Discovery World about Ensysce next generation opioids and explains PF614-MPAR, which just received FDA Breakthrough status.


Stock Day Podcast

Dr. Lynn Kirkpatrick talks about TAAP, MPAR and pain relief products

Stock Day Media – Dr. Lynn Kirkpatrick, Ensysce CEO, discusses the next generation of pain relief products, TAAP and MPAR plus a new collaboration designed to expand the Ensysce product portfolio.

Stock Day Media has the mission to bridge the gap between publicly traded small cap companies and investors via an aggregated news service.